Researchers at UC San Diego, in collaboration with UC Santa Cruz, have developed a new software tool for tracing and mapping the evolution of the SARS-CoV-2 virus, that is capable of handling the unprecedented amount of genetic data being generated by the quickly evolving pathogen.
A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by UC San Diego researchers. In mouse models of colon cancer, the therapy eliminated all tumors and prevented their recurrence.
A team of researchers involving UC San Diego has received a $25 million award from the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA) to build artificial coral reefs to protect coastal areas in Hawai’i against flooding, erosion and storm damage.
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
